Skip to main content

Atrial Fibrillation Market Detailed Analysis and Forecast up to 2026

Globally, the number of people affected by high blood pressure and large number of people are having valvular heart disease caused by rheumatic fever has resulted in atrial fibrillation. Growing incidence of obesity, hypertension, and diabetes has also resulted in different heart diseases leading the growth in the global atrial fibrillation. Moreover, increasing medical research and development activities and advancement seen in treatment and diagnoses of atrial fibrillation are also expected to expand the global atrial fibrillation market in the forthcoming years.
As per the data released in 2017 by the Centers for Disease Control and Prevention, 2.7–6.1 million individuals suffer from atrial fibrillation in the U.S. Increasing geriatric population is expected to add in the number in the coming years. Nearly 2% of the population under 65 years of age suffers from atrial fibrillation. Depending on these figures, there are high chances of growth in the global atrial filtration market.
Large number of geriatric population is a crucial factor that has surged growth in this market. Pertaining to these factors, the global atrial fibrillation market is likely to progress at 11.0% CAGR between 2017 and 2026. Rising at this rate, the market is expected to reach US$10.92 bn by the end of 2026.
EP Ablation Catheters to Hold Dominant Share in Atrial Fibrillation Market
The global atrial fibrillation market is categorized on the basis of product type, end user, and application. Based on product type the market is divided into EP diagnostic catheters, cardiac monitors, EP mapping and recording systems, EP ablation catheters, LAA closure, access devices, and others. Out of these, the demand for EP ablation catheters is competitively high than other products. Over the forecast tenure, this segment is expected to attain a valuation of US$2.7 bn by the end of 2026. In the meantime, EP mapping and recording systems are also expected to witness high growth over this period.
Request the Coronavirus Impact Analysis on this Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1541
The application of atrial fibrillation is seen in surgical, EP ablation, and diagnostics. Of these, the EP ablation segment is expected to hold larger share in the global atrial fibrillation market. In terms of end user, the market is segmented into hospitals, electrophysiology labs, and ambulatory surgical center. Among these end users, hospitals are projected to witness high demand over the projected tenure.
Europe Dominating Atrial Fibrillation Market Due to Advanced Healthcare Infrastructure
On the regional front, the global atrial fibrillation market covers North America, Europe, Latin America, the Middle East and Africa, and Asia Pacific. Among these, Europe is projected to lead the global atrial fibrillation market over the forecast period. Significant rise in adoption of advanced technologies and development of advanced healthcare infrastructure and facilities are the key factors fueling growth in the Europe atrial fibrillation market. Germany has a higher role in this market, as various catheter ablation procedures are performed in this region. This factor has further strengthen position of Europe in the global atrial fibrillation market.
In the competitive landscape section, the global atrial fabrillation market is likely to witness higher degree of competition due to the presence of large number of players operating in this market. In this report, researchers have analyzed few leading players including Biosense Webster, Inc., Medtronic Plc, Abbott Laboratories, Osypka AG, Biotronik SE & Co. KG, Boston Scientific Corporation, AtriCure Inc., MicroPort Scientific Corporation, CardioFocus, Inc., and Koninklijke Philips N.V.

Comments

Popular posts from this blog

Angioplasty Balloons & Stents Market Research Report | Forecast Until 2027

Complications with Existing Treatments to Drive Innovations The healthcare sector is no stranger to innovations and technological advancements. Research and development activities continue to improve the efficacy of treatments and bring forward new therapies to treat a range of diseases. Over the past couple of decades, minimally invasive procedures have gained a great amount of popularity within the healthcare sector. A similar trend can be observed within the angioplasty balloons & stents market as the adoption of minimally invasive procedures is on the rise, particularly among patients who have been diagnosed with coronary heart diseases or experienced a heart attack. Request Sample Of Report –   https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5627 At present, healthcare experts are focusing on minimizing the complications involved with the percutaneous coronary intervention (PCI) by leveraging the benefits of technology that conti...

Autoimmune Disease Diagnostics Market Analysis and Forecast up to 2023

Autoimmune Disease Diagnostics Market – Snapshot When immune system attacks the body mistakenly, then the resulting condition is known as autoimmune disease. Some of the autoimmune diseases are found more commonly in certain ethnicities than others. A case in point is high prevalence of lupus amongst the Hispanic and African-American group of people rather than Caucasians. The global autoimmune disease diagnostics market is estimated to make substantial gains due to rising incidences of autoimmune diseases across the globe. Request Sample Of Report –    https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5351 Some of the autoimmune diseases such as lupus and multiple sclerosis run within families. In that case, the family members will inherit vulnerability to the autoimmune illness that runs in the family but might not necessarily be affected by it. Increased Prevalence of Autoimmune Diseases to Spell Growth of the Market Many of the auto...

Analysis of COVID-19 Collagen Peptide and Gelatin Market

Collagen Peptide and Gelatin Market: Overview According to Transparency Market Research’s latest report on the global collagen peptide and gelatin market for the historical period  2017–2018  and forecast period  2019–2027 , increase in commercialization of novel collagen-based drug delivery systems and rise in social awareness about personal well-being are projected to drive the global collagen peptide and gelatin market According to the report, the global collagen peptide and gelatin market was valued at  US$ 5,976.9 Mn  in  2018  and is projected to expand at a CAGR of  8.7%  from  2019  to  2027 To know the scope of our report  Get a Sample  on Collagen Peptide and Gelatin Market Increase in social awareness about personal well-being and rigorous research and development activities in regenerative medicine and wound healing: Key Drivers Major factors driving the collagen peptide application in nutrac...